Sign in
4

Changes in Ownership

Mineralys Therapeutics, Inc. Filed Acc 0001933414-25-000149

Director sold 34,675 shares at an average $45.45 ($1,576,095)

  • Director acquired 34,675 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Gold Alexander M Director 2025-11-11 Option exercise +15,000 $10.20 $153,000 15,000 D
Gold Alexander M Director 2025-11-11 Sale −10,000 $42.43 $424,298 5,000 D
Gold Alexander M Director 2025-11-11 Sale −5,000 $47.08 $235,408 0 D
Gold Alexander M Director 2025-11-12 Option exercise +6,933 $10.20 $70,717 6,933 D
Gold Alexander M Director 2025-11-12 Sale −5,000 $46.50 $232,500 1,933 D
Gold Alexander M Director 2025-11-12 Sale −1,933 $47.28 $91,386 0 D
Gold Alexander M Director 2025-11-13 Option exercise +2,742 $10.20 $27,968 2,742 D
Gold Alexander M Director 2025-11-13 Option exercise +10,000 $12.69 $126,900 12,742 D
Gold Alexander M Director 2025-11-13 Sale −12,742 $46.50 $592,503 0 D
Derivatives
Gold Alexander M Director 2025-11-11 Option exercise · Stock Option −15,000 17,900 D
Gold Alexander M Director 2025-11-12 Option exercise · Stock Option −6,933 10,967 D
Gold Alexander M Director 2025-11-13 Option exercise · Stock Option −2,742 8,225 D
Gold Alexander M Director 2025-11-13 Option exercise · Stock Option −10,000 34,000 D
Open-market sales · 34,675 sh · avg $45.45 · $1,576,095
Loading xslF345X05/wk-form4_1763078474.xml…